Synthesis and evaluation of novel BTCP based affinity ligands for the dopamine reuptake complex.
Laboratory of Medicinal Chemistry, NIDDK, National Institutes of Health, Bethesda, MD 20892.
B R
BR
deCosta
R R
RR
Rothman
H
H
Akunne
A E
AE
Jacobson
K C
KC
Rice
D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D003042:Cocaine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D015259:Dopamine Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008024:Ligands; D010622:Phencyclidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*
D015259:Dopamine Agents; D008024:Ligands; D011954:Receptors, Dopamine; C056415:1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine; D003042:Cocaine; D010622:Phencyclidine; D004298:Dopamine